SLC16A3 and ovarian carcinoma: To validate our in silico findings, we have used cell lines which represent the similar type of Ovarian carcinoma as TCGA-Ovarian Cancer dataset and since MCT4-specific blocker is not available yet, we have tested the effects using a siRNA mediated knockdown approach.